XML 14 R4.htm IDEA: XBRL DOCUMENT v3.8.0.1
Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Sep. 30, 2017
Sep. 30, 2016
Revenues:        
Sales – ACM $ 250,502
Sales – Herbs 4,400
Total revenues 250,502 4,400
Cost of revenues:        
Product sales 58,801 5,100
Total cost of revenues 58,801 5,100
Gross Margin 191,701 (700)
Operating expenses:        
Research and development expenses
Selling, general and administrative expenses 230,875 178,470 592,822 434,176
Total operating expenses 230,875 178,470 592,822 434,176
Operating loss (230,875) (178,470) (401,121) (434,876)
Other income (expense):        
Interest expense (1,929) (798) (7,630) (2,257)
Net loss $ (232,804) $ (179,268) $ (408,751) $ (437,133)
Basic and diluted net loss per share (in dollars per share) $ (0.01) $ (0.01) $ (0.02) $ (0.02)
Weighted average shares outstanding – basic and diluted (in shares) 22,789,370 21,394,810 22,500,663 20,871,635